Chief Financial Officer of Travere Therapeutics, Inc. (NASDAQ:RTRX), Clague Laura, sells 7,500 shares worth $179,813
According to Travere Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 17 09:00 PM, company Chief Financial Officer, Clague Laura disclosed selling 7,500 shares at a cost of $23.98. At the time of this transaction (Nov 16), this trade was worth $179,813 in total. As of Nov 16, Clague Laura now owns 19,473 shares in total worth about $474,362.27999999997.
For the last few recent trades made by Travere Therapeutics, Inc. (NASDAQ:RTRX) Chief Financial Officer, Clague Laura, we have the following information:
- SEC Form 4 filing: Sep 23: Sold 1,500 shares at the rate of $18.48 per share. Total worth of this trade was $27,720. Total number of shares owned as of Sep 23 were 19,473
- SEC Form 4 filing: Sep 22: Sold 1,500 shares at the rate of $18.59 per share. Total worth of this trade was $27,885. Total number of shares owned as of Sep 22 were 20,973
- SEC Form 4 filing: May 11: Sold 1,250 shares at the rate of $14.95 per share. Total worth of this trade was $18,688. Total number of shares owned as of May 11 were 21,250
Posted by
George Daniels
on Tuesday November 17 2020, 11:24 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
